Blockade of the sonic hedgehog signalling pathway inhibits choroidal neovascularization in a laser-induced rat model

Abstract

Sonic hedgehog (Shh) signaling has recently been shown to be involved in the pathological angiogenesis in response to tissue hypoxia and ischemic injury. Hypoxia/ischemia is considered to play an important role in the development of choroidal neovascularization (CNV). This study was aimed to examine the effect of blockade of the Shh signaling pathway on CNV and the underlying mechanism. A total of 64 male Brown-Norway (BN) rats were used in this study. One eye of each rat underwent laser photocoagulation. The other eye served as normal control. After the laser treatment, the 64 rats were divided into four groups (n=16 in each group): Blank control group, in which no intravitreal administration was given; cyclopamine group, recombinant Shh N-terminals protein (rShh) group and phosphate-buffered saline (PBS) group, in which cyclopamine (a Shh inhibitor), rShh (a Shh activator) and PBS were intravitreally injected into the laser-treated eyes respectively every other day for a total of four intravitreal injections immediately after the laser treatment. Fourteen days after the intravitreal administration, the changes of CNV-related variables, including positive CNV lesion percentage, CNV membrane area and CNV membrane thickness, were evaluated by fluorescein angiography, indocyanine green angiography and pathological examinations. The mRNA and protein expression of PTCH1, Gli1, HIF-1_α, VEGF and DLL4 in each group on 14 days of CNV model was detected by real-time quantitative PCR and western blot analysis, and the relationship between the Shh cascade and the HIF-1_α-VEGF-DLL4 cascade in CNV was analyzed. The results showed that the CNV membrane area and the CNV membrane thickness were decreased by 62.5% and 41.9% in the cyclopamine group and increased by 85.7% and 64.3% in the rShh group in comparison to those in the blank control group (P<0.01 for each). There was no significant difference in the CNV membrane area and thickness between the blank control group and PBS group (P=0.102 and P=0.063, respectively). Real-time quantitative PCR revealed a 5.23-, 4.14-, 2.97-, 2.78- and 2.39-fold up-regulation of the mRNA expression of PTCH1, Gli1, HIF-1_α, VEGF and DLL4 genes in the laser-treated eyes compared with the normal control eyes in the control group. In the cyclopamine group, the mRNA and protein expression of Gli1, HIF-1_α, VEGF and DLL4 was significantly down-regulated (P<0.05 for each) while the expression of PTCH1 showed no significant changes at the mRNA (P=0.293) and protein level (P=0.304). The mRNA expression and protein expression (P=0.001 and P=0.021, respectively) of PTCH1, Gli1, HIF-1_α, VEGF and DLL4 was significantly increased in the rShh group when compared with the control group. The expression level of these genes was related to the severity of the CNV. It was concluded that intravitreal administration of cyclopamine can effectively inhibit the formation of laser-induced experimental CNV by down-regulating the expression of the HIF-1_α-VEGF-DLL4 cascade in CNV. The Shh signaling pathway as an upstream signaling pathway of HIF-1_α-VEGF-DLL4 cascade is implicated in the development of experimental CNV.

Keywords

Sonic hedgehog / choroidal neovascularization / therapeutics / hypoxia / ischemia

References

[1] FriedmanD.S., O’ColmainB.J., MunozB., et al.. Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol, 2004, 122(4): 564-572

[2] BresslerN.M., BresslerS.B., FineS.L.. Age-related macular degeneration. Surv Ophthalmol, 1988, 32(6): 375-413

[3] RossR.D., BarofskyJ.M., CohenG., et al.. Presumed macular choroidal watershed vascular filling, choroidal neovascularization, and systemic vascular disease in patients with age-related macular degeneration. Am J Ophthalmol, 1998, 125(1): 71-80

[4] StaritaC., HussainA.A., PagliariniS., et al.. Hydrodynamics of ageing Bruch’s membrane: Implications for macular disease. Exp Eye Res, 1996, 62(5): 565-572

[5] FeiglB.. Age-related maculopathy in the light of ischaemia. Clin Exp Optom, 2007, 90(4): 263-271

[6] OtaniA., TakagiH., OhH.. Vascular endothelial growth factor family and receptor expression in human choroidal neovascular membranes. Microvasc Res, 2002, 64(1): 162-169

[7] IshibashiT., HataY., YoshikawaH.. Expression of vascular endothelial growth factor in experimental choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol, 1997, 235(3): 159-167

[8] YangX.M., WangY.S., ZhangJ., et al.. Role of PI3K/Akt and MEK/ERK in mediating hypoxia-induced expression of HIF-1alpha and VEGF in laser-induced rat choroidal neovascularization. Invest Ophthalmol Vis Sci, 2009, 50(4): 1873-1879

[9] BrownD.M., RegilloC.D.. Anti-VEGF agents in the treatment of neovascular age-related macular degeneration: Applying clinical trial results to the treatment of everyday patients. Am J Ophthalmol, 2007, 144(4): 627-637

[10] BarouchF.C., MillerJ.W.. Anti-vascular endothelial growth factor strategies for the treatment of choroidal neovascularization from age-related macular degeneration. Int Ophthalmol Clin, 2004, 44(3): 23-32

[11] AfzalA., ShawL.C., LjubimovA.V.. Retinal and choroidal microangiopathies: Therapeutic opportunities. Microvasc Res, 2007, 74(2–3): 131-144

[12] ByrdN., GrabelL.. Hedgehog signaling in murine vasculogenesis and angiogenesis. Trends Cardiovasc Med, 2004, 14(8): 308-313

[13] KusanoK.F., PolaR., MurayamaT.. Sonic hedgehog myocardial gene therapy: Tissue repair through transient reconstitution of embryonic signaling. Nat Med, 2005, 11(11): 1197-1204

[14] LawsonN.D., VogelA.M., WeinsteinB.M.. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell, 2002, 3(1): 127-136

[15] KandaS., MochizukiY., SuematsuT.. Sonic hedgehog induces capillary morphogenesis by endothelial cells through phosphoinositide 3-kinase. J Biol Chem, 2003, 278(1): 8244-8249

[16] HwangJ.M., WengY.J., LinJ.A., et al.. Hypoxia-induced compensatory effect as related to Shh and HIF-1alpha in ischemia embryo rat heart. Mol Cell Biochem, 2008, 311(1–2): 179-187

[17] PolaR., LingL.E., SilverM.. The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med, 2001, 7(6): 706-711

[18] PolaR., LingL.E., AprahamianT.R., et al.. Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation, 2003, 108(4): 479-485

[19] AsaiJ., TakenakaH., KusanoK.F., et al.. Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation, 2006, 113(20): 2413-2424

[20] SuraceE.M., BalagganK.S., TessitoreA., et al.. Inhibition of ocular neovascularization by hedgehog blockade. Mol Ther, 2006, 13(3): 573-579

[21] GaoH., QiaoX., GaoR., et al.. Intravitreal triamcinolone does not alter basal vascular endothelial growth factor mRNA expression in rat retina. Vision Res, 2004, 44(4): 349-356

[22] EdelmanJ.L., CastroM.R.. Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res, 2000, 71(5): 523-533

[23] HeH., ZhangH., WangZ.T., et al.. Inhibitory effect of rgds peptide on experimental choroidal neovascularization in a rat model. Zhonghua Yan Ke Za Zhi (Chinese), 2006, 42(9): 825-831

[24] QuY., ZhangS., XuX., et al.. Octreotide inhibits choroidal neovascularization in rats. Ophthalmic Res, 2009, 42(1): 36-42

[25] QianY.S.. Sonic hedgehog expression and its role in form-deprivation myopia in mice. Curr Eye Res, 2009, 34(8): 623-635

[26] OlsonJ.L.. Intravitreal anakinra inhibits choroidal neovascular membrane growth in a rat model. Ocul Immunol Inflamm, 2009, 17(3): 195-200

[27] InghamP.W., McMahonA.P.. Hedgehog signaling in animal development: Paradigms and principles. Genes Dev, 2001, 15(23): 3059-3087

[28] PepinskyR.B., RayhornP., DayE.S.. Mapping sonic hedgehog-receptor interactions by steric interference. J Biol Chem, 2000, 275(15): 10995-11001

[29] Pasca di MaglianoM., HebrokM.. Hedgehog signalling in cancer formation and maintenance. Nat Rev Cancer, 2003, 3(12): 903-911

[30] KarlstromR.O., TyurinaO.V., KawakamiA., et al.. Genetic analysis of zebrafish gli1 and gli2 reveals divergent requirements for gli genes in vertebrate development. Development, 2003, 130(8): 1549-1564

[31] KuboM., NakamuraM., TasakiA., et al.. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res, 2004, 64(17): 6071-6074

[32] ChenJ.K., TaipaleJ., CooperM.K., et al.. Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev, 2002, 16(21): 2743-2748

[33] SoletiR., BenameurT., PorroC., et al.. Microparticles harboring Sonic Hedgehog promote angiogenesis through the upregulation of adhesion proteins and proangiogenic factors. Carcinogenesis, 2009, 30(4): 580-588

[34] KyokoF., TakeshiM., ShizuyaS.. Sonic hedgehog: Its expression in a healing cornea and its role in neovascularization. Mol Vis, 2009, 15(5): 1036-1044

[35] OzturkH., TuncerM.C., OzturkH., et al.. Nitric oxide regulates expression of Sonic hedgehog and hypoxia-inducible factor-1alpha in an experimental model of kidney ischemia-reperfusion. Ren Fail, 2007, 29(3): 249-256

[36] DokucuA.I., OzturkH., OzturkH., et al.. The effects of molsidomine on hypoxia inducible factor alpha and Sonic hedgehog in testicular ischemia/reperfusion injury in rats. Int Urol Nephrol, 2009, 41(1): 101-108

[37] PughC.W., RatcliffeP.J.. Regulation of angiogenesis by hypoxia: Role of the HIF system. Nat Med, 2003, 9(6): 677-684

[38] InoueY., YanagiY., MatsuuraK., et al.. Expression of hypoxia-inducible factor 1alpha and 2alpha in choroidal neovascular membranes associated with age-related macular degeneration. Br J Ophthalmol, 2007, 91(12): 1720-1721

[39] DouG.R., WangY.C., HuX.B., et al.. RBP-J, the transcription factor downstream of Notch receptors, is essential for the maintenance of vascular homeostasis in adult mice. FASEB J, 2008, 22(5): 1606-1617

[40] PatelN.S., LiJ.L., GeneraliD., et al.. Up-regulation of delta-like 4 ligand in human tumor vasculature and the role of basal expression in endothelial cell function. Cancer Res, 2005, 65(19): 8690-8697

[41] D’AmoreP.A., NgY.S.. Won’t you be my neighbor? Local induction of arteriogenesis. Cell, 2002, 110(3): 289-292

[42] KatohY., KatohM.. Comparative genomics on HHIP family orthologs. Int J Mol Med, 2006, 17(1): 391-395

[43] LiuZ.J., ShirakawaT., LiY., et al.. Regulation of Notch1 and Dll4 by vascular endothelial growth factor in arterial endothelial cells: Implications for modulating arteriogenesis and angiogenesis. Mol Cell Biol, 2003, 23(1): 14-25